2021 - BCBSTX
Adults age 45-75 for colorectal cancer using: Guaiac Fecal Occult Blood Test (gFOBT) annually or; Fecal Immunochemical Testing (FIT) annually or; Fecal Immunochemical Testing (FIT)-DNA every 1-3 years or; Flexible
Download 2021 - BCBSTX
Information
Domain:
Source:
Link to this page:
Documents from same domain
May 2018 Eligibility & Benefits IVR Caller Guide 800 …
www.bcbstx.comEligibility & Benefits IVR Caller Guide May 2018 • Utilize your key pad when possible • Avoid using cell phones • Minimize background noise • …
Blue Advantage HMOSM and Blue PremierSM …
www.bcbstx.comBlue EssentialsSM (formerly known as HMO Blue Texas SM), Blue Advantage HMOSM and Blue PremierSM Provider Manual - Filing Claims Updated 12-21-2016 Page F - 1 A Division of Health Care Service Corporation, a Mutual Legal Reserve Company, an Independent Licensee of the Blue Cross and Blue Shield Association
Quick Guide to Blue Cross and Blue Shield Member …
www.bcbstx.comQuick Guide to Blue Cross and Blue Shield Member ID Cards A Division of Health Care Service Corporation, a Mutual Legal Reserve Company, an Independent Licensee of the Blue Cross and Blue Shield Association
SummaryofBenefitsandCoverage: …
www.bcbstx.comAllcopaymentandcoinsurancecostsshowninthischartareafteryourdeductiblehasbeenmet,ifadeductibleapplies. Limitations,Exceptions,&OtherImportant Information
CPCP003 Evaluation and Management of …
www.bcbstx.com2 If observation services are billed with any of the ED associated Evaluation and Management codes, MCG. TM . criteria will be used to evaluate the medical necessity of these observation
2017-2018 Preventive Care Guidelines Table of …
www.bcbstx.com2 Divisions of Health Care Service Corporation, a Mutual Legal Reserve Company, an Independent Licensee of the Blue Cross and Blue Shield Association
2017 Formulary (List of Covered Drugs) - Blue Cross …
www.bcbstx.com2017 Formulary (List of Covered Drugs) Blue Cross Medicare Advantage (HMO) SM. Blue Cross Medicare Advantage (HMO-POS) SM. Blue Cross Medicare Advantage (PPO)
Federal Employee Program (FEP) Quick Reference …
www.bcbstx.comUpdated A Division of Health Care Service Corporation, a Mutual Legal ReserveAugust 26, 2015 Company, an Independent Licensee of the Blue Cross and Blue Shield Association page 2of Claims Submission: All claims should be submitted electronically.
October 2015 COMMONLY PRESCRIBED …
www.bcbstx.comOctober 2015 COMMONLY PRESCRIBED PREFERRED DRUGS . Drug trademarks and servicemarks are the property of their respective third-party owners. A Division of Health Care Service Corporation, a Mutual Legal Reserve Company, an Independent Licensee of the Blue Cross and Blue Shield Association
Inpatient Unbundling Policy - Blue Cross Blue …
www.bcbstx.com1. In the event of conflict between a Clinical Payment and Coding Policy and any plan document under which a member is entitled to Covered …
Related documents
FECAL OCCULT BLOOD DETECTION (HEMOCCULT TEST)
www.sfgh-poct.orgWhen a fecal specimen containing occult blood is applied to the test paper, contact is made between hemoglobin and guaiac. A chemical reaction will occur upon addition of the developer solution, resulting in a blue discoloration of the paper within 60 seconds.
TESTS GRANTED WAIVED STATUS UNDER CLIA CPT …
www.cdc.govDec 05, 2014 · Fecal occult blood : Various . Detection of blood in feces from whatever cause, benign or malignant (colorectal cancer screening) 82962. Blood glucose by glucose monitoring devices cleared by the FDA for home use: Various. Monitoring of blood glucose levels: 83026. Hemoglobin by copper sulfate – non-automated: Various. Monitors hemoglobin ...
CRC Screening: FIT vs Cologuard (FIT-DNA)
www.cdphp.comCRC Screening: FIT vs Cologuard (FIT-DNA) Effectiveness, convenience, and cost are the three factors that determine which tests to pursue with a patient who is resistant to screening colonoscopy (as well as flexible sigmoidoscopy or CT colonography). Effectiveness: Though it is often cited that Cologuard has a sensitivity of 92% compared with FIT’s sensitivity of 74%, it is …
Interpretive Guide - GDX
www.gdx.netFecal Secretory IgA Fecal Secretory IgA <dL Fecal Secretory IgA > 885 mcg/g Suggestive of loss of resilience Suggestive of GI immune upregulation in the gut 4,11 Fecal Occult Blood positive Assess for cause of bleeding • (i.e., Ulcers, polyps, diverticulitis, IBD, colorectal cancer, etc.) • Consider Selective IgA Deficiency
STOOL TESTING SUPPORT GUIDE - GDX
www.gdx.netFecal Occult Blood • Color • • Consistency • • MIC Sensitivities, Yeast or Bacteria • • • + Add-ons 2203 Clostridium difficile EIA + + + 2204 Shiga toxin E. coli EIA + + + 2202 Campylobacter spp. EIA + + + 2206 Fecal Lactoferrin + + 2208 Helicobacter pylori EIA + + + 2331 Macro Exam for Worms + + • 2336 Zonulin Family Peptide + +
CLINICAL LABORATORY APPLICATION
www.health.pa.govMar 10, 2014 · Fecal Occult Blood Fecal Occult Blood Instrument Blood Glucose (incl. Whole Blood) Blood Gases Therapeutic Drug Monitoring PSA Testing Synovial Fluid Glycohemoglobin (A1C) Theophylline Electrolytes Fructosamine pH of Body Fluids HDL Cholesterol LDL Cholesterol Triglycerides TSH Rapid BNP